These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications. Linenberger ML; Price TH J Intensive Care Med; 2005; 20(2):88-103. PubMed ID: 15855221 [TBL] [Abstract][Full Text] [Related]
43. [Pathophysiology and therapy of pruritus in cholestatic liver diseases]. Schachschal G; Schmidt H Z Gastroenterol; 2003 Jun; 41(6):627. PubMed ID: 12806549 [No Abstract] [Full Text] [Related]
44. Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases. Milewski B; Palynyczko Z Pol Med Sci Hist Bull (1973); 1975; 15(5-6):551-5. PubMed ID: 1228704 [TBL] [Abstract][Full Text] [Related]
45. [Preoperative hemosorption in cancer patients with mechanical jaundice]. Lisetskiĭ VA; Starosel'skiĭ IV; Kaban AP; Fokin AV; Chernyĭ VA Vopr Onkol; 1986; 32(12):46-9. PubMed ID: 3798838 [TBL] [Abstract][Full Text] [Related]
46. [Bile sorption in hepatic insufficiency in patients with mechanical jaundice]. Zhidovinov GI Khirurgiia (Mosk); 1989 Jul; (7):88-92. PubMed ID: 2796201 [TBL] [Abstract][Full Text] [Related]
47. [Liver function in the indication of surgical interventions in the upper abdomen]. Eisenburg J Munch Med Wochenschr; 1968 Dec; 110(52):3020-7. PubMed ID: 5756506 [No Abstract] [Full Text] [Related]
48. [Experiences with preoperative and palliative percutaneous transhepatic cholangio-drainage]. Arlart IP; von Dewitz H; Fritz W Rofo; 1986 Mar; 144(3):267-72. PubMed ID: 2421374 [TBL] [Abstract][Full Text] [Related]
50. [The clinico-pathogenetic variants of cholestasis in different liver diseases]. Ivashkin VT; Ivlev AS; Pliusnin SV; Vasil'ev AP Ter Arkh; 1992; 64(2):6-9. PubMed ID: 1509386 [TBL] [Abstract][Full Text] [Related]
51. [Effect of alvesin on the blood coagulation system and on vascular permeability in patients with mechanical jaundice]. Krivitskiĭ DI; Pavlovskiĭ DP; Poliakov NG; Paratsiĭ ZZ; Shuliarenko VA Vrach Delo; 1986 Sep; (9):64-7. PubMed ID: 3788121 [No Abstract] [Full Text] [Related]
52. Evaluation of percutaneous cholangiography and percutaneous biliary drainage in obstructive jaundice. Lukes P; Ceder S; Wihed A; Falk A; Gamklou R Eur J Radiol; 1985 Nov; 5(4):267-70. PubMed ID: 4085489 [TBL] [Abstract][Full Text] [Related]
53. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease. Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449 [TBL] [Abstract][Full Text] [Related]
54. [Therapeutic effect of the transfusion of UV-irradiated donor plasma in mechanical jaundice]. Kolesova OE; Leont'eva GV; Apollonova LA; Chilingirov RKh; Bobkov IuI Biull Eksp Biol Med; 1986 Mar; 101(3):282-4. PubMed ID: 3955210 [TBL] [Abstract][Full Text] [Related]